Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Environmental Health Perspectives|July 29, 2010
Respiratory health effects of exposure to low-NOx unflued gas heaters in the classroom: a double-blind, cluster-randomized, crossover studyGuy B Marks, Wafaa Ezz, Nathan Aust, et al.
Plos One|December 5, 2012
Respiratory health before and after the opening of a road traffic tunnel: a planned evaluationChristine T Cowie, Nectarios Rose, Wafaa Ezz, et al.
Pediatric Nephrology (Berlin, Germany)|October 11, 2017
The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytomaJohn J Bissler, David N Franz, Michael D Frost, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2018
Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2John J Bissler, Klemens Budde, Matthias Sauter, et al.
Gastroenterology|September 22, 2009
Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitisWilliam J Sandborn, Jaroslaw Regula, Brian G Feagan, et al.
Neuromuscular Disorders : NMD|December 6, 2017
A randomized placebo-controlled phase 3 trial of an antisense oligonucleotide, drisapersen, in Duchenne muscular dystrophyNathalie Goemans, Eugenio Mercuri, Elena Belousova, et al.
Plos One|September 8, 2018
Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosisJohn J Bissler, Norio Nonomura, Klemens Budde, et al.
Plos One|August 10, 2017
Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 studyJohn J Bissler, J Chris Kingswood, Elzbieta Radzikowska, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2015
Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trialJohn J Bissler, John Christopher Kingswood, Elżbieta Radzikowska, et al.
Plos One|June 29, 2016
Long-Term Use of Everolimus in Patients with Tuberous Sclerosis Complex: Final Results from the EXIST-1 StudyDavid N Franz, Elena Belousova, Steven Sparagana, et al.
Pageof 5